Equillium (EQ) Current Assets (2017 - 2026)
Equillium (EQ) posted quarterly Current Assets of $62.3 million for Q1 2026, up 284.03% year-over-year from $16.2 million in Q1 2025, and up 100.64% quarter-over-quarter from $31.0 million in Q4 2025.
Equillium (EQ) Current Assets (2017 - 2026) Analysis & Trends
Equillium (EQ) has reported Current Assets for 10 consecutive years, with $62.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 284.03% year-over-year to $62.3 million; the TTM figure through Mar 2026 stood at $62.3 million (up 284.03% YoY), while the FY2025 annual figure was $31.0 million, up 24.26% from the prior year.
- Current Assets grew to $62.3 million in Q1 2026 per EQ's latest filing, from $31.0 million in the prior quarter.
- Across five years, Current Assets topped out at $76.7 million in Q4 2022 and bottomed at $12.0 million in Q2 2025.
- Historically, Current Assets has averaged $46.2 million across 5 years, with a median of $46.8 million in 2022.
- Annual changes were most pronounced in 2025 — Current Assets plunged 71.47% — and 2026, when it jumped 284.03%.
- Equillium's Current Assets stood at $76.7 million in 2022, then sank by 35.69% to $49.3 million in 2023, then tumbled by 49.38% to $25.0 million in 2024, then grew by 24.26% to $31.0 million in 2025, then soared by 100.64% to $62.3 million in 2026.
- Business Quant data shows EQ's Current Assets at $62.3 million in Q1 2026, $31.0 million in Q4 2025, and $33.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - | 57.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.98 Mn |
| Mar 31, 2026 | 62.28 Mn |
| Dec 31, 2025 | 31.04 Mn |
| Sep 30, 2025 | 33.58 Mn |
| Jun 30, 2025 | 11.95 Mn |
| Mar 31, 2025 | 16.22 Mn |
| Dec 31, 2024 | 24.98 Mn |
| Sep 30, 2024 | 33.65 Mn |
| Jun 30, 2024 | 41.89 Mn |
| Mar 31, 2024 | 42.48 Mn |
| Dec 31, 2023 | 49.35 Mn |
| Sep 30, 2023 | 53.91 Mn |
| Jun 30, 2023 | 57.36 Mn |
| Mar 31, 2023 | 70.22 Mn |
| Dec 31, 2022 | 76.74 Mn |
| Sep 30, 2022 | 46.78 Mn |
| Jun 30, 2022 | 60.48 Mn |
| Mar 31, 2022 | 72.09 Mn |
| Dec 31, 2021 | 83.37 Mn |
| Sep 30, 2021 | 92.17 Mn |